ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

Clinical trial NCT06973161 · COMPLETED

Trial details

NCT number: NCT06973161
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Bladder Cancer Biliary Tract Cancer Cervical Cancer Endometrial Cancer Ovarian Cancer Pancreatic Cancer Colorectal Cancer Lung Cancer Other Tumors

Start date: 2025-06-10
Primary completion: 2026-03-17
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.